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1. Introduction
Minimally invasive approach for colorectal surgery 
promotes functional recovery and reduces length of 
stay without compromising oncological outcome (1-
3). Enhanced recovery after surgery (ERAS) pathways 
advocate minimally invasive surgery to decrease surgical 
stress, morbidity, length of stay and costs (4). ERAS 
care protocols including multimodal pain management 
strategies aim to facilitate recovery by an opioid-
sparing attitude to avoid opioid-related side effects (5). 
Epidurals have been shown to be efficient after open 
surgery (6), and modern pain management strategies 
including intravenous lidocaine, wound infiltration or 
transverse abdominis plane (TAP) block emerge as 
alternatives for minimally invasive surgery (7). Most 
studies comparing open and laparoscopic surgery stated 
less pain after minimally invasive surgery (8,9), but only 
scarce data reporting on pain scores and actual analgesics 
consumption is available.
 The aims of the present study were to compare pain 
management strategies in patients undergoing open 
and minimally invasive colorectal surgical procedures, 
to analyse pain perception in both settings and to 
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identify risk factors for insufficient pain control in the 
postoperative period.
2. Materials and Methods
2.1. Study design
This is a prospective cohort study including all consecutive 
adult patients (≥ 18 years) who underwent elective or 
emergent colorectal surgery in the Department of Visceral 
Surgery at Lausanne University Hospital (CHUV), 
Switzerland, between January 2014 and April 2015. 
Perioperative confusion or language disorders represented 
exclusion criteria. For patients operated several times, only 
the first procedure was retained for the present analysis.
 The prospective pain database was part of a quality 
improvement project and informed consent was waived 
by the Institutional Review Board. The study was 
carried out in line with the STROBE statement (10) 
and registered under www.researchregistry.com (UIN 
researchregistry 2292).
2.2. Surgical details
Colorectal surgical procedures included open and 
minimally invasive surgeries. Converted procedures 
were accounted for in the minimally invasive group 
in an intention-to-treat analysis. Rectum resection, 
proctocolectomy and total colectomy were regrouped as 
extended surgery, in contrast to segmental colectomy, 
stoma procedures (i.e. ileostomy closure and Hartmann 
reversal) and small bowel surgery. Small bowel surgery 
regrouped segmental resections of the terminal ileum and 
different procedures related to Crohn's disease. Further 
were recorded the setting (elective vs. emergency) and 
the duration of the procedure. All patients were treated 
within a comprehensive Institutional enhanced recovery 
(ERAS) protocol (11) with standardized care maps.
2.3. Pain management
Type and amount of administered analgesics was recorded 
in a prospectively maintained database. Intraoperatively, 
fentanyl or sufentanyl were administered in most 
patients followed by paracetamol, metamizole and 
ibuprofen (according to ERAS caremap) at the end of 
the procedure unless contraindicated. Perioperative pain 
was managed as follows: Epidural analgesia (EDA) 
was applied for open procedures unless contraindicated 
(anticoagulant therapy, sepsis or patient refusal) and 
maintained for 48 or 72 hours according to ERAS 
protocol and type of surgery with a relay medication 
comprising oxycodone (oxycontin® and oxynorm®). 
EDA was inserted at thoracic level (Th 8-10) before 
induction, and iterative boluses of bupivacaïne 0.25% 
or 0.5% were administered during the intervention, 
followed by a solution containing bupivacaine 0.0625%, 
fentanyl 2 ug/mL and adrenaline 2 ug/mL for the 
postoperative period. For minimally invasive procedures 
and open procedures with EDA contraindication, iv 
lidocaine (1.5 mg/kg for induction, then 2 mg/kg/h until 
recovery room) (12) and iv ketamine (0.25 mg/kg bolus 
followed by 0.25 mg/kg/h, maximum 1mg/kg) (13) were 
applied unless contraindicated (lidocaine: hepatic failure 
or lidocaine intolerance, ketamine: age > 70 years, 
ischemic heart disease or psychotic pathology). As an 
alternative, ultrasound-guided transversus abdominis 
plane (TAP) blocks and surgical wound infiltration using 
bupivacaine 0.25% or naropin 0.25% were applied upon 
anaesthesiologists' discretion.
 Postoperative use of opioids (morphine, oxycodone, 
buprenorphine, tramadol) were recorded from recovery 
room (RR) until 96 hours postoperatively. 
 Standardized conversion factors were used to 
calculate morphine equivalents (14): iv or sc morphine 
(3×), oral oxycodone (2×), oral buprenorphine (75×), 
oral tramadol (0.1×). Total morphine equivalents were 
recorded for the following time periods: 24 h (including 
RR until the end of the first postoperative day), 48 h, 72 
h and 96 h.
2.4. Data collection
Data regarding different demographic (age, gender, 
body mass index (BMI) and American Society of 
Anaesthesiologists (ASA) score), surgery- and pain 
management-related items as specified above was 
entered in a computerized database, which was 
prospectively maintained by the anaesthesiology care 
team (MC and CB) and a dedicated study nurse. Visual 
analogue scales (VAS) were used by two clinical nurses 
to assess pain at rest and at mobilization (0: no pain-10: 
maximal pain) at the following time points: RR, arrival 
patient's room, 2 h, 6 h, 12 h, 24 h, 36 h, 48 h, 72 h and 
96 h. Clinical nurses were blinded to pain management 
protocols and/or actual pain medication consumption 
of the patient. Insufficient pain control was defined as 
VAS score of ≥ 4 (15). 
2.5. Outcomes/study endpoints
The primary endpoint was postoperative pain perception 
as measured by VAS. After propensity score matching, 
patients experiencing insufficient pain control (VAS 
≥ 4) were compared with patients with sufficient pain 
control (VAS < 4), and independent risk factors for 
insufficient pain control within 24 hours from surgery 
were identified by multivariate logistic regression.
2.6. Statistical analysis
Anonymized data analysis was performed using the 
Stata Software v. 14.2 (StataCorp, College Station, 
TX, USA). Categorical data was summarized as raw 
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underwent colorectal procedures during the study period. 
One hundred and fifty-six (47%) were performed by 
an open approach, while 176 (53%) were performed by 
laparoscopy. Nineteen (6%) laparoscopic procedures 
were converted to open approach and remained 
assigned to minimal invasive procedures according to 
the intention-to-treat principle. Demographic, surgery-
related and pain management-related items before 
propensity score matching are displayed in Table 1.
3.2. Pain scores
Propensity score matching of the two groups (open 
vs. laparoscopic) led to a dropout of 125 patients 
frequencies and group percentages. Differences in 
categorical data distributions between groups were 
assessed using the chi-squared test, or the Fisher's exact 
test in case of insufficient sample size. Continuous 
data distribution was analyzed using Normal QQ-
Plots. Gaussian data were summarized as mean and 
standard deviation (SD), while non-Gaussian data were 
summarized as median, interquartile range (IQR) and 
range. Differences in means between two groups for 
Gaussian data were assessed using the Student's t-test. 
Differences in distribution between two groups for non-
Gaussian data were assessed using the Wilcoxon-Mann-
Whitney ranksum test. 
 As the two study groups (open vs. laparoscopic) 
differed on several major characteristics, propensity 
score matching was performed. The propensity score 
was derived using a probit regression model with the 
following cofactors: age, gender, ASA score, surgery 
type (right colectomy, left colectomy, stoma procedure, 
rectum resection, small bowel) and setting (elective vs. 
emergency). Matching of the laparoscopic group to the 
open group was performed to the nearest neighbour 
with replacement. Figure 1 shows the Kernel plot of the 
propensity score. Univariate and multivariate logistic 
regression was used to assess the association between 
several factors and binary outcomes. A p-value < 0.05 
was considered statistically significant. 
3. Results
3.1. Patients
Three hundred and thirty-two consecutive patients 
Table 1. Demographic, surgical and anaesthesia-related items
Items
Age (years) (median, IQR)
Gender
     Female (%)
     Male (%)
BMI (kg/m2) (median, IQR)
ASA group
     I-II (%)
     III-IV (%)
Type of surgery (%)
     Left colectomy
      Right colectomy
      Rectum resection
      Stoma procedure
      Small bowel
Extended (%)     
Emergency (%)
Duration of surgery (min) (median, IQR)












  73 (22)
  60 (18)
  44 (13)
  74 (22)
  81 (25)




  72 (22)
114 (34)
  27 (8)
  38 (11)
Open (n = 156)
68, 56-78
  70 (45)
  86 (55)
24, 21-29
  86 (55)
  70 (45)
  14 (9)
  22 (14)
  14 (9)
  69 (44)
  37 (24)
  15 (10)
  48 (31)
163, 98-224
205, 140-276
  57 (37)
  17 (11)
  20 (13)
  25 (16)
MI – Body Mass Index, ASA – American Society of Anesthesiologists, TAP – Transversus Abdominis Plane. Bold characters indicate significant 
values (p < 0.05).
Minimal invasive (n = 176)
62, 51-72
  89 (51)
  87 (49)
25, 21-28
128 (73)
  48 (27)
  59 (34)
  38 (22)
  30 (17)
    5 (3)
  44 (25)
  36 (21)
  52 (30)
181, 124-261
235, 163-306
  15 (9)
  97 (55)
    7 (4)
  13 (7)
   P
   0.004
   0.3
   0.581
< 0.001
< 0.001
   0.006
   0.808
   0.016
   0.014
< 0.001
< 0.001
   0.003
   0.014
Figure 1. Propensity score matching. Kernel density plot 
with comparison of the two groups (open vs. minimally 
invasive) before (above) and after (below) propensity score 
matching.
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(38%) (Figure 1). Mean VAS scores for pain were 
< 3 for both comparative groups throughout the 
entire postoperative observation period, at rest and at 
mobilization. Mean VAS scores for minimal-invasively 
operated patients were significantly higher than for 
open procedures until 48 hours, at rest and mobilization 
(p < 0.05), while patients undergoing open procedures 
had significantly higher mean VAS scores at 72 and 
96 hours at mobilization (p < 0.05) (Figure 2). More 
patients operated by minimally invasive surgery had 
insufficient pain control (VAS≥4) at 24 hours (19% vs. 
5%, p < 0.05), while more patients in the open group 
experienced pain peaks (≥ 4) during mobilization 
at 72-96 hours (45% vs. 22%, p < 0.05) (Figure 3). 
Among the minimally invasive procedures, mean 
scores were similar throughout the observed time 
span when comparing patients receiving opioids only, 
patients receiving opioids and lidocaine and patients 
receiving opioids, lidocaine and ketamine, at rest 
and at mobilization (Figure 4). Morphine equivalent 
consumption was similar when comparing these 3 
groups (Figure 4c).
3.3. Risk factors for insufficient pain control (VAS ≥ 4) 
within 24 hours
Independent risk factors for insufficient pain control (≥ 
4) were duration of procedure (Odds Ratio (OR) 3.37, 
95% Confidence Interval (CI) 2.03-5.59), emergency 
surgery (OR 3.01, 95%CI 1.72-5.31), wound infiltration 
(OR 3.23, 95%CI 0.97-10.70), age < 70 years (OR 2.03, 
95% CI 1.18-3.48) and ASA I-II score (OR 2.06, 95% CI 
1.19-3.56) (Figure 5).
4. Discussion
Despite overall low pain scores throughout the 
observed time span, insufficient pain control (VAS ≥ 4) 
represented a problem in the early postoperative phase 
in patients operated by minimal invasive approach, 
while open procedures were associated with pain peaks 
(≥ 4) at 72-96 hours. This coincides with retrieval of 
epidurals within ERAS care and hence insufficient 
management of pain relay. Further, multimodal pain 
management concepts did not appear to be beneficial in 
Figure 2. Evolution of pain scores over time (a) at rest, (b) 
at mobilization. Evolution of mean pain scores over time by 
comparing open and minimally invasive procedures at rest and 
at mobilization. × indicates statistical significance (p < 0.05). 
VAS – Visual Analog Scale, S.E.M. – Standard Error of the 
Mean, Recovery – Recovery room, Room – Arrival patient's 
room, h – hours.
Figure 3. Patients with insufficient pain control (VAS ≥ 
4) (a) at rest, (b) at mobilization. Percentage of patients 
experiencing pain peaks (VAS ≥ 4) over time by comparing 
open and minimal invasive procedures at rest and at 
mobilization. × indicates statistical significance (p < 0.05). VAS 
– Visual Analog Scale, 95% CI – 95% Confidence Interval
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the present cohort.
 Adequate pain control after major abdominal 
surgery is the major concern of patients before surgery 
and directly related to their opinion on caregivers 
(16,17). Pain management is one important item of 
ERAS in colorectal surgery (18). Mid-thoracic epidural 
anaesthesia (EDA) is advocated for open procedures (6), 
while the evidence is less clear for minimal invasive 
surgery. EDA was associated with controversial 
results regarding postoperative morbidity (19,20) 
and slowed down recovery after laparoscopic surgery 
without evident benefits in recent randomized trials 
(21,22). Instead, numerous alternatives for peri- and 
postoperative pain management have been suggested 
for minimal invasive surgery, and the combination of 
different strategies in a multimodal concept has been 
advocated (7,23). However, despite this diversity, pain 
remains undermanaged even within enhanced recovery 
protocols (24), and a recent meta-analysis did not show 
any superiority of pain management within ERAS care 
regarding pain scores, length of stay and functional 
recovery (25). 
 Multimodal pain management strategies including 
non-opioid analgesia (i.e. acetaminophen and non-
steroidal anti-inflammatory drugs), local infiltration 
or TAP blocks and intravenous lidocaine aim to 
decrease opioid consumption. This is important within 
enhanced recovery protocols, since opioids have 
been shown to impede prompt functional recovery 
by favoring postoperative nausea and vomiting, ileus 
and respiratory depression (24). However, despite a 
consensus for opioid-sparing management, multimodal 
treatment is not standardized, as shown by a recent 
large quality improvement survey (26), and opioids 
in different forms and combinations including patient 
controlled analgesia remain a mainstay of postoperative 
pain management (27).
 In the present analysis, all patients were treated 
within an enhanced recovery protocol, and thus opioid-
sparing therapy was part of perioperative care. EDA, 
intravenous lidocaine, TAP block and wound infiltration 
were used in different combinations according to 
Figure 4. Pain scores and morphine requirements after 
laparoscopy (a) at rest, (b) at mobilization. Evolution of 
mean pain scores over time by comparing minimally invasively 
operated patients receiving perioperative opiates, opiates and 
lidocaine or opiates, lidocaine and ketamine. (c) Morphine 
requirements. Mean morphine equivalent consumption over 
time by comparing minimally invasively operated patients 
receiving perioperative opiates, opiates and lidocaine or opiates, 
lidocaine and ketamine. VAS – Visual Analog Scale, 95% CI – 
95% Confidence Interval, Recovery – Recovery room, Room – 
Arrival patient's room, h - hours
Figure 5. Independent risk factors for pain peaks (VAS ≥ 4) 
at 24 hours. Multivariable analysis of univariate risk factors 
for pain peaks (VAS ≥ 4) at 24 hours postoperatively. ASA – 
American Society of Anaesthesiologists, min – minutes, VAS 
– Visual Analog Scale, 95% CI – 95% Confidence Interval, 
Infiltration – perioperative wound infiltration
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anaesthesiologist's discretion. Overall pain scores 
were low in the present cohort and compare well to 
previous reports on pain perception (26,27). However, 
pain scores were higher after minimally invasive 
surgery compared to open surgery, with up to 45% 
of patients experiencing pain peaks at mobilization 
during the first postoperative day. This contrasts with 
the repeatedly proven efficiency of minimal invasive 
surgery in decreasing postoperative pain (8,28,29). 
Two explanations might account for this discrepancy. 
First, EDA was efficient after open surgery in the 
present cohort, as pictured by a low number of patients 
with significant pain during the first 2, respectively 
3 postoperative days with EDA in place. However, a 
significant increase of insufficient pain control (VAS ≥ 
4) at 72 hours indicates suboptimal management of pain 
relay. Since pain relay medication was standardized 
according to guidelines within ERAS care maps, 
reasons for this insufficient backup strategy might be 
the lack of proper surveillance of pain at EDA retrieval 
(30). Second, pain management after minimally 
invasive surgery was suboptimal and wound infiltration 
was even retained as independent risk factor for 
insufficient pain control within 24 hours in the present 
analysis (Figure 5). Park found in a recent randomized 
controlled trial that wound infiltration was less effective 
than TAP block in decreasing postoperative opioid 
consumption (31). A recent meta-analysis showed that 
novel infiltration techniques such as wound catheter, 
TAP block, and intraperitoneal instillation led to a 
decrease in pain scores (32). TAP block was rarely 
applied in the present cohort, but might represent an 
alternative to conventional wound infiltration (5,33). 
Another reason for insufficient pain relief by wound 
infiltration might be a lack of proper follow-up with 
consequent insufficient administration of backup pain 
medication. Taken together, the main reasons for higher 
pain levels in laparoscopic patients in the first 24 hours 
are an underestimation of actual pain after minimally 
invasive surgery and an overrating of multimodal pain 
strategies. The latter aspect was clarified by a subgroup 
analysis of 3 different pain strategies in laparoscopic 
patients as shown in the following paragraph.
 In the present study, patients consumed the same 
amount of morphine equivalents postoperatively, 
regardless of adding on lidocaine and ketamine 
(Figure 4c). Intravenous lidocaine has been shown to 
reduce pain scores, intra- and postoperative analgesic 
requirements and to promote functional recovery (34). 
However, a recent Cochrane review questioned the 
efficiency of intravenous lidocaine and particularly 
its impact on pain scores, especially in the early 
postoperative phase, similar to the findings of the 
present cohort (12). Ketamine as a powerful blocker of 
nociceptive and inflammatory pain transmission proved 
efficiency in decreasing postoperative pain in recent 
trials (35,36). However, the optimal dose needs to be 
determined by further clinical trials (37).
 The present study showed thus inconclusive results 
using the applied multimodal pathway, and opioids 
remained a mainstay treatment even within an enhanced 
recovery pathway.
 Several limitations need to be addressed. The 
study cohort was heterogeneous and modest in size, 
and no data on chronic pain issues was available for 
this analysis. Further, intraoperative pain management 
strategies were not standardized. However, perioperative 
care pathway was standardized (ERAS care) and 
applied with high compliance and in line with current 
recommendations. Furthermore, consecutive non-
selected patients ("all-comers") were reported limiting 
selection bias and reflecting a "real-world" situation.
 In conclusion, overall, pain was well controlled in 
a non-selected cohort of colorectal surgical patients, 
but pain peaks remained a major concern despite close 
adherence to ERAS guidelines including modern pain 
strategies. Multimodal pain concepts could not decrease 
morphine consumption in the present cohort. Efforts 
should focus on providing evidence-based standardized 
care protocols regarding pain management in minimally 
invasive surgery and for patients after open surgeries 
without or after removal of epidural catheter.
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